Related Experiment Videos
Oral vaccination against enteric bacterial infections: an overview
Abstract:
The present situation and the future prospects for the use of oral vaccines against the major enteric diseases typhoid fever, shigellosis and cholera are discussed in this paper. No significant protection could be demonstrated for oral inactivated whole-cell vaccines. In contrast, an oral live vaccine based on the attenuated Salmonella typhi strain Ty 21a was highly efficacious in volunteer challenge studies and in a controlled field trial. Two attenuated strains are presently being tested in volunteer studies as candidate vaccines against shigellosis; one uses S. typhi Ty 21a and the other Escherichia coli K-12 as the carrier for shigella antigens. Experimental challenge studies in volunteers showed that recovery from clinical cholera confers solid and long-lasting protection. The goal of present research is to develop a vaccine that mimics the events of clinical cholera without causing disease.
Insights
Oral vaccines show promise for enteric diseases like typhoid fever and cholera. Live attenuated Salmonella Typhi strain Ty 21a demonstrated high efficacy, offering hope for future disease prevention.
Area of Science:
- Microbiology
- Vaccinology
- Infectious Diseases
Background:
- Enteric diseases such as typhoid fever, shigellosis, and cholera pose significant global health challenges.
- Current vaccine strategies for these diseases are under continuous development and evaluation.
- Oral vaccine delivery offers potential advantages in terms of ease of administration and immunogenicity.
Purpose of the Study:
- To review the current status and future potential of oral vaccines against major enteric pathogens.
- To evaluate the efficacy of different oral vaccine candidates for typhoid fever, shigellosis, and cholera.
- To discuss ongoing research aimed at developing novel oral vaccines for these diseases.
Main Methods:
- Review of existing literature on oral vaccine development and efficacy studies.
- Analysis of data from volunteer challenge studies and field trials for oral vaccines.
- Discussion of experimental approaches for developing new vaccine candidates, including attenuated strains and carrier systems.
Main Results:
- Oral inactivated whole-cell vaccines demonstrated no significant protection against enteric diseases.
- An oral live vaccine utilizing the attenuated Salmonella Typhi strain Ty 21a showed high efficacy in challenge studies and field trials.
- Recovery from clinical cholera provides robust, long-lasting protection, guiding vaccine development.
Conclusions:
- Live attenuated oral vaccines, particularly those based on Salmonella Typhi Ty 21a, show significant promise for controlling enteric diseases.
- Further research is focused on developing vaccines that mimic natural immunity without causing illness.
- Oral vaccine technology holds potential for improved prevention of typhoid fever, shigellosis, and cholera.